A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2006
12/20/2006	EP1357903B1 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4- 2-(PIPERIDIN-1-YL) ETHOXY\|PHENOXY)-2-(4-METHOXYPHENYL) BENZO b\|THIOPHENE AND SALTS THEREOF
12/20/2006	EP1317537B1 G-csf analog compositions and methods
12/20/2006	EP1276720B1 2-acyl indol derivatives and their use as anti-tumour agents
12/20/2006	EP1263729B1 Azacyclic compounds for use in the treatment of serotonin related diseases
12/20/2006	EP1202967B1 Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester
12/20/2006	EP1194164B1 Prion protein peptides and uses thereof
12/20/2006	EP1187816B1 5-cyano-2-aminopyrimidine derivatives
12/20/2006	EP1172107B1 Drugs containing sulfopyranosylacylglycerol derivatives
12/20/2006	EP1135477B1 Humanized monoclonal integrin antibodies
12/20/2006	EP1131294B1 Quinoline derivatives as nk-2 and nk-3 receptor ligands
12/20/2006	EP1027027B1 Use of amylin, adrenomedullin and analogues thereof for treating cartilage defects
12/20/2006	EP0972032B1 Peptides for the treatment of systemic lupus erythematosus
12/20/2006	EP0966442B1 Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity
12/20/2006	CN1882549A 7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors
12/20/2006	CN1882345A 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of RAF kinase for treatment of cancer
12/20/2006	CN1882342A Use of CHK1 inhibitors to control cell proliferation
12/20/2006	CN1882330A Composition for promoting synthesis of collagen, and composition for external preparation for skin comprising the same
12/20/2006	CN1880306A Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/20/2006	CN1880304A Triamide-substituted indoles, benzofuranes and benzothiophenes
12/20/2006	CN1879840A A nano 'Xing Nao Jing' injection and method for preparing same
12/20/2006	CN1879827A A compound preparation for resisting chicken heat stress
12/20/2006	CN1879816A Chinese medicinal composition for promoting growth of meat chicken and method for preparing same
12/20/2006	CN1879812A Chinese medicinal composition for increasing egg production rate of layer and method for preparing same
12/20/2006	CN1879777A Blood circulation-invigorating tendon-strengthening preparation and method for preparing same
12/20/2006	CN1879761A A health product for regulating immunity and resisting mutation and method for preparing same
12/20/2006	CN1879733A A medicinal liquor for treating leg cramp and preparation method thereof
12/20/2006	CN1879653A Bezoar nano-powder preparation process and pharmaceutical preparation thereof
12/20/2006	CN1879630A Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol
12/20/2006	CN1879629A Estrogen replacement therapy
12/20/2006	CN1291002C Natural Yin-nourishing and Yang-strengthening tonic wine and its prepn process
12/20/2006	CN1290858C Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof
12/20/2006	CN1290848C Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/20/2006	CN1290847C Aza-arylpiperazines
12/20/2006	CN1290846C Pyrazolo[1,5-a]pyridines and medicaments containing thereof
12/20/2006	CN1290844C Dihydro Indolinone derivatives used as protein kinase inhibitor
12/20/2006	CN1290843C Polymorph of acid 4-[2-[4-[1-2-ethoxyethyl]-1h-benzimidazole-2-il]-1-piper idinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic acid
12/20/2006	CN1290842C Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
12/20/2006	CN1290833C N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris
12/20/2006	CN1290832C 1h-indole derivatives as a highly selective cyclooxygenase-2 inhibitor
12/20/2006	CN1290826C Novel substituted propanamide benzoyl urea derivatives, medicinal composition containg same and use thereof
12/20/2006	CN1290825C Or tho-substituted and meta-substituted bis-aryl compounds, method for production thereof, their use as medicament, and pharmaceutical preparations containing there compounds
12/20/2006	CN1290813C Process for the preparation of non-steroidal glucocorticoid receptor modulators
12/20/2006	CN1290775C Method and device for manufacturing advanced water containing ultra-fine gold particles
12/20/2006	CN1290581C Remedy for hypertension
12/20/2006	CN1290576C Use of thymic hormone beta 15 in preparation of substances for promoting wound healing and generation of blood
12/20/2006	CN1290560C Medication in use for relieving fatigue and preparation method
12/20/2006	CN1290515C Poly(allylamine hydrochloride) with low salt content
12/20/2006	CN1290506C Medicinal composition
12/20/2006	CN1290504C Combination comprising combretastatin and anticancer agents
12/20/2006	CN1290501C Pharmaceutically active isoindoline derivatives
12/20/2006	CN1290500C Retroviral protease inhibitor combinations
12/19/2006	US7151191 Such as 3-(4-salicyloylamino)phenoxypropionic acid; noncovalent drug delivery
12/19/2006	US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
12/19/2006	US7151159 Amino acid sequences for therapeutic and prophylactic use against diseases due to clostridium difficile toxins
12/19/2006	US7151109 Psychological disorders; anxiolytic agents; antidepressants
12/19/2006	US7151108 Anticarcinogenic, antiproliferative, and antitumor agents
12/19/2006	US7151107 A quaternary ammonium salts of 1-{2-(3'-chlorobiphenyl-4-yl)-2-oxoethyl}-4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydropyridine; used as neuroprotectants, for prophylaxis of brain and nervous system disorders, Alzheimer's disease, senile dementia
12/19/2006	US7151106 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
12/19/2006	US7151103 A serotonin receptor antagonists for therapeutic treatment
12/19/2006	US7151098 Glutamate receptor antagonists
12/19/2006	US7151095 Oral and rectal drug delivery of a mixture of 4-aminophenylacetic acid and 5-aminosalicylic acid; antiinflammatory agents for gastrointestinal tract; antiulcer agents; bis(sodium carboxyl phenyl)azo compounds
12/19/2006	US7151090 Methods for enhancing graft survival by modulating heme oxygenase activity
12/19/2006	US7150983 Modified proteolytic enzyme for treatment of osteoarthritis
12/19/2006	US7150869 Gene therapy; cytokine complex; anticancer agent
12/19/2006	CA2358062C Controlled release galantamine composition
12/19/2006	CA2297268C Ready-to-use aqueous compound for dyeing keratic fibres comprising the association of a water-soluble solvent and a nonionic or anionic amphiphilic polymer comprising at least onefatty chain
12/19/2006	CA2296560C Amino acid derivatives useful to treat stroke
12/19/2006	CA2259538C Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
12/19/2006	CA2194761C Immunomodulatory oligonucleotides
12/19/2006	CA2155200C Use of topical anesthetics for the treatment of eosinophil-associated diseases
12/19/2006	CA2149496C 11,21-bisphenyl-19-norpregnane derivatives
12/14/2006	WO2006132440A1 Solid preparation
12/14/2006	WO2006132438A1 1,3-benzothiazinone derivative and use thereof
12/14/2006	WO2006132436A1 Heterocyclic compound
12/14/2006	WO2006132432A1 Therapeutic agent for neurogenic pain
12/14/2006	WO2006132352A1 Pharmaceutical composition containing sc(fv)2
12/14/2006	WO2006132275A1 Prophylactic and/or therapeutic agent for motor disorder
12/14/2006	WO2006132273A1 Composition comprising peptide having suppressive effect on food intake
12/14/2006	WO2006132251A1 Prophylactic/therapeutic agent for adult t cell leukemia
12/14/2006	WO2006132248A1 Method for ubiquitination of runx
12/14/2006	WO2006132236A1 Mobilizer of leukocyte and/or hematopoietic stem/progenitor cell
12/14/2006	WO2006132205A1 Radical scavenger and active oxygen eliminating agent
12/14/2006	WO2006132204A1 Transcription factor decoy
12/14/2006	WO2006132197A1 HETEROCYCLIC COMPOUND HAVING TYPE I 11β HYDROXYSTEROID DEHYDROGENASE INHIBITORY ACTIVITY
12/14/2006	WO2006132196A1 NOVEL PHARMACEUTICAL COMPRISING β3 AGONIST
12/14/2006	WO2006132189A1 Screening method for neuronal differentiation inducer
12/14/2006	WO2006132177A1 Human cell differentiation inducer and product containing the same
12/14/2006	WO2006094246A3 N-arylmethyl benzamide sirtuin modulators
12/14/2006	WO2006081444A3 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
12/14/2006	US20060281905 Crystallization of IGF-1
12/14/2006	US20060281820 Lfa-1 inhibitors and use thereof
12/14/2006	US20060281798 Methods of using thiazolidinedithione derivatives
12/14/2006	US20060281795 Benzinidazole Derivative and Use As AII Receptor Antagonist
12/14/2006	US20060281789 Protein kinase inhibitors
12/14/2006	US20060281742 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
12/14/2006	US20060281738 2-Naphthylimino-1,3-thiazine derivative
12/14/2006	US20060281734 3-[5-(3-acetamidobenzamido)-2-methylphenyl]-6-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-4-one for example; treating rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease; inhibitor of cytokine-mediated disease
12/14/2006	US20060281719 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
12/14/2006	US20060281706 New phosphonate ester derivatives of drugs such as antivirals cidofovir, adefovir, tenofovir, azidothymidine (AZT), or bisphosphonates such as alendronate, or anticancers such as cytosine arabinoside; side effect reduction, less toxic; antiviral
12/14/2006	US20060281679 Human FGF-23 gene and gene expression products

1 ... 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 ... 1564